These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11286846)

  • 1. Effects of Motexafin gadolinium on tumor metabolism and radiation sensitivity.
    Xu S; Zakian K; Thaler H; Matei C; Alfieri A; Chen Y; Koutcher JA
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1381-90. PubMed ID: 11286846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.
    Miller RA; Woodburn K; Fan Q; Renschler MF; Sessler JL; Koutcher JA
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):981-9. PubMed ID: 10571206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluating gadolinium(III) texaphyrin as a radiosensitizing agent.
    Bernhard EJ; Mitchell JB; Deen D; Cardell M; Rosenthal DI; Brown JM
    Cancer Res; 2000 Jan; 60(1):86-91. PubMed ID: 10646858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species.
    Magda D; Lepp C; Gerasimchuk N; Lee I; Sessler JL; Lin A; Biaglow JE; Miller RA
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1025-36. PubMed ID: 11704327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of texaphyrins on the oxygenation of EMT6 mouse mammary tumors.
    Donnelly ET; Liu Y; Fatunmbi YO; Lee I; Magda D; Rockwell S
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1570-6. PubMed ID: 15050338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay.
    Donnelly ET; Liu Y; Paul TK; Rockwell S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1176-86. PubMed ID: 15990023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
    Rosenthal DI; Nurenberg P; Becerra CR; Frenkel EP; Carbone DP; Lum BL; Miller R; Engel J; Young S; Miles D; Renschler MF
    Clin Cancer Res; 1999 Apr; 5(4):739-45. PubMed ID: 10213207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120.
    Drugs R D; 2004; 5(1):52-7. PubMed ID: 14725495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by beta-D-iodinated azomycin galactopyranoside (beta-D-IAZGP), and radiation sensitivity.
    Saitoh J; Sakurai H; Suzuki Y; Muramatsu H; Ishikawa H; Kitamoto Y; Akimoto T; Hasegawa M; Mitsuhashi N; Nakano T
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):903-9. PubMed ID: 12377344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
    Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive high-performance liquid chromatographic assay for motexafin gadolinium and motexafin lutetium in human plasma.
    Parise RA; Miles DR; Egorin MJ
    J Chromatogr B Biomed Sci Appl; 2000 Dec; 749(2):145-52. PubMed ID: 11145051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy.
    Hwang YC; Kim SG; Evelhoch JL; Seyedsadr M; Ackerman JJ
    Cancer Res; 1991 Jun; 51(12):3108-18. PubMed ID: 1904001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.
    Carde P; Timmerman R; Mehta MP; Koprowski CD; Ford J; Tishler RB; Miles D; Miller RA; Renschler MF
    J Clin Oncol; 2001 Apr; 19(7):2074-83. PubMed ID: 11283141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model.
    Yamaguchi A; Woodburn KW; Hayase M; Robbins RC
    Circulation; 2000 Nov; 102(19 Suppl 3):III275-80. PubMed ID: 11082401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation enhancement by biochemical modulation and 5-fluorouracil.
    Koutcher JA; Alfieri AA; Thaler H; Matei C; Martin DS
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1145-52. PubMed ID: 9392557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
    Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
    Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo 31P nuclear magnetic resonance measurements of metabolic changes post radiation.
    Mahmood U; Alfieri AA; Ballon D; Traganos F; Koutcher JA
    Cancer Res; 1995 Mar; 55(6):1248-54. PubMed ID: 7882317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 31P NMR spectroscopic study of bioenergetic changes in radiation-induced fibrosarcoma-1 after radiation therapy.
    Rajan SS; Wehrle JP; Li SJ; Steen RG; Glickson JD
    NMR Biomed; 1989 Nov; 2(4):165-71. PubMed ID: 2641498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy.
    Mahmood U; Alfieri AA; Thaler H; Cowburn D; Koutcher JA
    Cancer Res; 1994 Sep; 54(18):4885-91. PubMed ID: 8069854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd-Tex Pharmacyclics Inc.
    Radford IR
    Curr Opin Investig Drugs; 2000 Dec; 1(4):524-8. PubMed ID: 11249709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.